| DB ID | MyCo_6342 |
| Title | Ceruloplasmin, transferrin and apolipoprotein A-II play important role in treatment's follow-up of paracoccidioidomycosis patients |
| Year | 2018 |
| PMID | 30359420 |
| Fungal Diseases involved | Paracoccidioidomycosis |
| Associated Medical Condition | None |
| Genus | Paracoccidioides |
| Species | brasiliensis |
| Organism | Paracoccidioides brasiliensis |
| Ethical Statement | The study was approved by the Research Ethics Committee of the Faculty of Medicine of Botu-catu—UNESP, number 2,100,907, CAAE submission 21822813.9.0000.5411. |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Serum |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | Apolipoprotein A-II |
| Biomarker Full Name | Apolipoprotein A-II |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Brazil |
| Cohort | A retrospective study was performed in patients attending the Clinical Mycology Outpatient Ser- vice of the Discipline of Infectious and Parasitic Diseases of the Faculdade de Medicina de Botu-catu–São Paulo State University–UNESP. Nine patients with PCM were studied and characterizedas either confirmed or probable cases. |
| Cohort No. | 9 |
| Age Group | None |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Bioinformatics analysis |
| Analysis Method | Proteomics Approach |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | Proteomics Approach |
| Up Regulation Down Regulation | Positive |
| Sequence Data | None |
| External Link | None |
